Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06967545 · ClinicalTrials.gov registry record · NA
A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior
A NA study of Suicide Attempt and Suicide Ideation, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06967545: Recruiting NA study of Suicide Attempt and Suicide Ideation, sponsored by Massachusetts General Hospital.
NCT06967545 is a NA study of Suicide Attempt and Suicide Ideation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 20 participants, below the 243-participant average among 13 other Suicide Attempt trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06967545, a NA study of Suicide Attempt and Suicide Ideation, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to evaluate the acceptability, safety, and preliminary efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.
Primary Outcome
(i) Indexed as the proportion of TEC-S sessions accessed within the first week, (ii) adapted items from the Credibility/Expectancy Questionnaire (CEQ), rated on a 9-point scale. : "How satisfied were you with your overall experience with TEC-S?" "How satisfied were you with your understanding of how to complete TEC-S (iii)End-User Mobile Application Rating Scale (uMARS), with items rated on a 5-point scale.
Conditions Studied
Interventions
- BEHAVIORAL Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06967545 shows while recruiting
NCT06967545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 243-participant average among 13 other Suicide Attempt trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Suicide Attempt appearing as the primary indexed condition, and to 1 intervention - of which Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S) is the first listed.
NCT06967545 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06967545 about?
NCT06967545 is a clinical study titled "A One-Arm Open Trial of a Smartphone Delivered Treatment for Suicidal Thoughts and Behavior". This study aims to evaluate the acceptability, safety, and preliminary efficacy of a smartphone-delivered intervention called Therapeutic Evaluative Conditioning for Suicide (TEC-S) in reducing suicidal thoughts and behaviors (STB) among adults with recent and frequent suicide ideation.
What is the current status of trial NCT06967545?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-01-20. Estimated completion is 2026-12-31.
What conditions does trial NCT06967545 study?
This clinical trial studies the following conditions: Suicide Attempt, Suicide Ideation.
What interventions are being tested in trial NCT06967545?
The interventions under investigation include: Smartphone-delivered Therapeutic Evaluative Conditioning for Suicide (TEC-S) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06967545?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06967545 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide Attempt
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06967545's enrollment target sits among peer trials
20 14th of 13 the lowest of 13 other Suicide Attempt trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide Attempt trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part A
RECRUITING · NA
-
Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD
RECRUITING · NA
-
Teen Recovery Through Inspiration, Support, and Empowerment
RECRUITING · NA
-
Efficacy of the I-CARE Digital Health Intervention
RECRUITING · NA
-
Swift Outpatient Alternatives for Rapid Stabilization
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI